Your browser doesn't support javascript.
loading
Alemtuzumab significantly improves posterior fossa syndrome presented as a relapse of multiple sclerosis.
Signoriello, E; D'Amico, A; Fratta, M; Ugga, L; Altobelli, C; Conchiglia, G; Barbarulo, A M; Di Pietro, A; Anastasio, P; Rossi, F; Lus, G.
Afiliação
  • Signoriello E; Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy. Electronic address: elisabetta.signoriello@unicampania.it.
  • D'Amico A; Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
  • Fratta M; Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Ugga L; Department of Advanced Biomedical Sciences, University of Naples "Federico II", Naples, Italy.
  • Altobelli C; Unit of Nephrology, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Conchiglia G; Alma Mater, Villa Camaldoli Hospital, Naples, Italy.
  • Barbarulo AM; Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Di Pietro A; Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Anastasio P; Unit of Nephrology, Department of Translational Medical Sciences, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Rossi F; Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy.
  • Lus G; Multiple Sclerosis Center, II Division of Neurology, University of Campania Luigi Vanvitelli, Naples, Italy.
Mult Scler Relat Disord ; 38: 101518, 2020 Feb.
Article em En | MEDLINE | ID: mdl-31778927
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sintomas Comportamentais / Encefalopatias / Esclerose Múltipla Recidivante-Remitente / Disfunção Cognitiva / Alemtuzumab / Fatores Imunológicos / Mutismo Limite: Adult / Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sintomas Comportamentais / Encefalopatias / Esclerose Múltipla Recidivante-Remitente / Disfunção Cognitiva / Alemtuzumab / Fatores Imunológicos / Mutismo Limite: Adult / Humans Idioma: En Revista: Mult Scler Relat Disord Ano de publicação: 2020 Tipo de documento: Article